Ten priorities for expanding access to HCV treatment for people who inject drugs in low- and middle-income countries
Authors:
- 1 November 2015
- journal article
- Published by Elsevier in International Journal of Drug Policy
- Vol. 26 (11) , 1088-1093
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Simplification of antiviral hepatitis C virus therapy to support expanded access in resource-limited settingsJournal of Hepatology, 2014
- Continued low uptake of treatment for hepatitis C virus infection in a large community‐based cohort of inner city residentsLiver International, 2013
- Treatment of Hepatitis C Virus Infection Among People Who Are Actively Injecting Drugs: A Systematic Review and Meta-analysisClinical Infectious Diseases, 2013
- Peer Support Models for People With a History of Injecting Drug Use Undertaking Assessment and Treatment for Hepatitis C Virus InfectionClinical Infectious Diseases, 2013
- Models of Care for the Management of Hepatitis C Virus Among People Who Inject Drugs: One Size Does Not Fit AllClinical Infectious Diseases, 2013
- Task shifting of antiretroviral treatment from doctors to primary-care nurses in South Africa (STRETCH): a pragmatic, parallel, cluster-randomised trialThe Lancet, 2012
- Treatment of Hepatitis C as Prevention: A Modeling Case Study in VietnamPLOS ONE, 2012
- The first decade of antiretroviral therapy in AfricaGlobalization and Health, 2011
- HIV Testing, Human Rights, and Global AIDS Policy: Exceptionalism and Its DiscontentsJournal of Health Politics, Policy and Law, 2009
- Global estimates of prevalence of HCV infection among injecting drug usersInternational Journal of Drug Policy, 2007